Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9173497 | Journal of Vascular Surgery | 2005 | 6 Pages |
Abstract
GAH is a serious complication with high morbidity, mortality, and transfusion requirements. Although technical problems are preventable, FPV grafts, like all biologic grafts, can develop disruption with GAH from ongoing infection, especially in severely immunocompromised patients who are malnourished and have poor healing ability. Strategies for prevention and alternative treatment modalities are appropriate in patients at high risk for GAH.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Ahsan T. MD, Christopher MD, J. Gregory MD, R. James MD, G. Patrick MD,